Highbridge Capital Management LLC Acquires New Position in Kenvue Inc. $KVUE

Highbridge Capital Management LLC acquired a new stake in shares of Kenvue Inc. (NYSE:KVUE) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 1,174,353 shares of the company’s stock, valued at approximately $20,258,000.

A number of other institutional investors have also recently made changes to their positions in KVUE. Cornerstone Planning Group LLC boosted its holdings in shares of Kenvue by 705.2% during the 3rd quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock valued at $25,000 after acquiring an additional 1,361 shares during the last quarter. Physician Wealth Advisors Inc. boosted its holdings in shares of Kenvue by 67.5% during the 4th quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock valued at $26,000 after acquiring an additional 618 shares during the last quarter. Elyxium Wealth LLC purchased a new stake in shares of Kenvue during the 4th quarter valued at about $26,000. SBI Securities Co. Ltd. boosted its holdings in shares of Kenvue by 82.4% during the 4th quarter. SBI Securities Co. Ltd. now owns 2,273 shares of the company’s stock valued at $39,000 after acquiring an additional 1,027 shares during the last quarter. Finally, Atlantic Union Bankshares Corp boosted its holdings in shares of Kenvue by 184.1% during the 3rd quarter. Atlantic Union Bankshares Corp now owns 2,619 shares of the company’s stock valued at $43,000 after acquiring an additional 1,697 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Insider Buying and Selling at Kenvue

In other news, General Counsel Matthew Orlando sold 38,491 shares of the stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $17.66, for a total value of $679,751.06. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. 1.59% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on KVUE shares. Argus raised shares of Kenvue to a “hold” rating in a report on Friday, March 6th. Barclays dropped their price target on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a report on Tuesday, April 14th. UBS Group dropped their price target on shares of Kenvue from $19.00 to $18.00 and set a “neutral” rating on the stock in a report on Tuesday, April 7th. Zacks Research raised shares of Kenvue from a “hold” rating to a “strong-buy” rating in a report on Friday, May 8th. Finally, Canaccord Genuity Group raised their price target on shares of Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a report on Wednesday, February 18th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and twelve have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $19.33.

Kenvue Price Performance

Shares of NYSE:KVUE opened at $17.72 on Friday. The firm’s 50 day moving average price is $17.37 and its 200-day moving average price is $17.48. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $22.87. The company has a quick ratio of 0.70, a current ratio of 0.98 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $34.01 billion, a PE ratio of 20.84, a price-to-earnings-growth ratio of 1.28 and a beta of 0.54.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Thursday, May 7th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.05. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The firm had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $3.84 billion. During the same quarter in the prior year, the business earned $0.24 EPS. The business’s quarterly revenue was up 4.5% on a year-over-year basis. Equities research analysts expect that Kenvue Inc. will post 1.16 EPS for the current year.

Kenvue Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 27th. Stockholders of record on Wednesday, May 13th were paid a $0.2075 dividend. This represents a $0.83 annualized dividend and a dividend yield of 4.7%. The ex-dividend date was Wednesday, May 13th. Kenvue’s dividend payout ratio is 97.65%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.